A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials

Sleep Medicine

Volumn 4, Issue 1, 2003, Pages 57-62

  McCall, W Vaughn ^a   D'Agostino Jr , Ralph ^a   Dunn, Aaron ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Ethics; Hypnotics; Meta analysis; Placebo; Sleeping pills

Indexed keywords

FLURAZEPAM; HYPNOTIC AGENT; MIDAZOLAM; PLACEBO; TRAZODONE; ZALEPLON; ZOLPIDEM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; HUMAN; INSOMNIA; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; TREATMENT OUTCOME;

EID: 12244295469     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1389-9457(02)00242-3     Document Type: Article

References (34)

1. Chengappa KN, Tohen M, Levine J, Jacobs T, et al. Response to placebo among bipolar I disorder patients experiencing their first manic episode. Bipolar Disord 2000;2(4):332-335.
2. Manschreck TC. Placebo studies: lessons from psychiatric research. Psychiatr Ann 2001;31:130-136.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
4. Nicolis FB, Silvestri LG. Hypnotic activity of placebo in relation to severity of insomnia: a quantitative evaluation. Clin Pharmacol Ther 1967;8(6):841-848.
5. Roehrs T, Vogel G, Vogel F, Wittig R, et al. Eligibility requirements in hypnotic trials. Sleep 1985;8(1):34-39.
6. Roehrs T, Vogel G, Roth T. Rebound insomnia: its determinants and significance. Am J Med 1990;88(3A):39S-42S.
7. Zung WW. The effect of placebo and drugs on human sleep. Biol Psychiatry 1973;6(1):89-92.
8. Musa MN. Paroxetine for primary insomnia: possible placebo effect? J Clin Psychiatry 1999;60(11):795.
9. Hajak G, Rodenbeck A, Voderholzer U, Riemann D, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001;62(6):453-463.
10. Monti JM, Alvarino F, Cardinali D, Savio I, et al. Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia. Arch Gerontol Geriatr 1999;28:85-98.
11. Bixler EO, Vgontzas AN, Kales A. Methodological issues in pharmacological studies of sleep. Pharmacology of sleep. Berlin: Springer, 1995. pp. 323-343.
12. Adam K, Adamson L, Brezinova V, Oswald I. Do placebos alter sleep? Br Med J 1976;1(6003):195-196.
13. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. J Am Med Assoc 1997;278(24):2170-2177.
14. Holbrook AM, Crowther R, Lotter A, Cheng C, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 2000;162(2):225-233.
15. Gillin JC, Rapaport M, Erman MK, Winokur A, et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 1997;58(5):185-192.
16. Fontaine R, Ontiveros A, Elie R, Kensler TT, et al. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55(6):234-241.
17. Cohn JB, Bowden CL, Fisher JG, Rodos JJ. Double-blind comparison of buspirone and clorazepate in anxious outpatients. Am J Med 1986;80(3B):10-16.
18. Diagnostic Classification Steering Committee TMC. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: TMC, 1990.
19. Rechtshaffen A, Kales A. A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. Los Angeles, CA: UCLA Brain Information Service, 1968.
20. Hedges L, Olkin I. Statistical methods for meta-analysis. Orlando, FL: Academic Press, 1985.
21. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, et al. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. J Am Med Assoc 2001;285(14):1856-1864.
22. Kripke DF, Hauri P, Ancoli-Israel S, Roth T. Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990;10(4 Suppl):32S-43S.
23. Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994;55(5):192-199.
24. Walsh JK, Erman M, Erwin CW, Jamieson A, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol Clin Exp 1998;13:191-198.
25. Walsh JK, Vogel GW, Scharf M, Erman M, et al. A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 2000;1(1):41-49.
26. Herrmann WM, Kubicki ST, Boden S, Eich FX, et al. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation. J Int Med Res 1993;21(6):306-322.
27. Carskadon MA, Dement WC, Mitler MM, Guilleminault C, et al. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 1976;133(12):1382-1388.
28. Frankel BL, Coursey RD, Buchbinder R, Snyder F. Recorded and reported sleep in chronic primary insomnia. Arch Gen Psychiatry 1976;33(5):615-623.
29. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344(21):1594-1602.
30. Steinmark SW, Borkovec TD. Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. J Abnorm Psychol 1974;83(2):157-163.
31. Carr-Kaffashan L, Woolfolk RL. Active and placebo effects in treatment of moderate and severe insomnia. J Consult Clin Psychol 1979;47(6):1072-1080.
32. Walsh JK, Roth T, Randazzo A, Erman M, et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000;23(8):1087-1096.
33. Anonymous. Guidelines for the clinical evaluation of hypnotic drugs. Washington, DC: US Department of Health, Education and Welfare, Food and Drug Administration, 1977.
34. McCall WV, Fleischer Jr AB, Feldman SR. Diagnostic codes associated with hypnotic medications during outpatient physician-patient encounters in the United States from 1990-1998. Sleep 2002;25(2):221-223.